✦ LIBER ✦

Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours

✍ Scribed by Janson, Eva M.Tiensuu; Ahlström, Håkan; Andersson, Torbjörn; Öberg, Kjell E.

Book ID: 122563188
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 544 KB
Volume: 28
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(92)90060-F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined treatment of malignant mesothel

Combined treatment of malignant mesothelioma (MM) of the pleura with high dose Methotrexate (Mtx), and interferons alfa (IFA) and gamma (IFG)

✍ Brodin, O; Knuuttila, A; Halme, M; Strander, H; LindÈn, C.J; Hillerdal, G; Matts 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Comparison between combination therapy w

Comparison between combination therapy with peg-interferon alfa-2A plus ribavirin and peg-interferon alfa-2B plus ribavirin in the treatment of chronic hepatitis C

✍ M. Capanni; M.R. Biagini; S. Nanni; E. Lorefice; M. Paci; M.C. Benini; E. Gai; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB

982 Pegylated interferon alfa-2B in comb

982 Pegylated interferon alfa-2B in combination with ribavirin for the treatment of chronic hepatitis C genotype 4

✍ HASAN, F; ASKER, H; ALKHALDI, J; SIDDIQUE, I; OWAID, S; ALAJMI, M; ALNAKIB, B 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Interferon alfa-2b in combination with r

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh

Everolimus plus octreotide long-acting r

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

✍ Marianne E Pavel; John D Hainsworth; Eric Baudin; Marc Peeters; Dieter Hörsch; R 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 392 KB

Low-Dose Cyclophosphamide and Interferon

Low-Dose Cyclophosphamide and Interferon Alfa 2a for the Treatment of Capillary Hemangioma of the Orbit

✍ Matthew W. Wilson; Mary Ellen Hoehn; Barrett G. Haik; Martha Rieman; Ulrike Reis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 578 KB